nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCB1—colon cancer	0.483	1	CbGaD
Levetiracetam—ABCC2—Irinotecan—colon cancer	0.119	0.314	CbGbCtD
Levetiracetam—ABCC2—Vincristine—colon cancer	0.104	0.274	CbGbCtD
Levetiracetam—ABCC2—Methotrexate—colon cancer	0.063	0.166	CbGbCtD
Levetiracetam—ABCB1—Irinotecan—colon cancer	0.0388	0.102	CbGbCtD
Levetiracetam—ABCB1—Vincristine—colon cancer	0.0339	0.0894	CbGbCtD
Levetiracetam—ABCB1—Methotrexate—colon cancer	0.0205	0.0541	CbGbCtD
Levetiracetam—ABCC2—bile—colon cancer	0.00705	0.362	CbGeAlD
Levetiracetam—SV2A—vagina—colon cancer	0.00304	0.156	CbGeAlD
Levetiracetam—SV2A—lymph node—colon cancer	0.00197	0.101	CbGeAlD
Levetiracetam—CACNA1B—lymph node—colon cancer	0.00136	0.0698	CbGeAlD
Levetiracetam—ABCC2—renal system—colon cancer	0.000939	0.0483	CbGeAlD
Levetiracetam—ABCC2—digestive system—colon cancer	0.00077	0.0396	CbGeAlD
Levetiracetam—ABCB1—blood vessel—colon cancer	0.000748	0.0384	CbGeAlD
Levetiracetam—ABCC2—liver—colon cancer	0.000574	0.0295	CbGeAlD
Levetiracetam—ABCB1—embryo—colon cancer	0.000446	0.0229	CbGeAlD
Levetiracetam—ABCC2—lymph node—colon cancer	0.00044	0.0226	CbGeAlD
Levetiracetam—Pharyngitis—Fluorouracil—colon cancer	0.000392	0.0033	CcSEcCtD
Levetiracetam—Face oedema—Capecitabine—colon cancer	0.000386	0.00325	CcSEcCtD
Levetiracetam—Mediastinal disorder—Vincristine—colon cancer	0.000382	0.00322	CcSEcCtD
Levetiracetam—Irritability—Capecitabine—colon cancer	0.000381	0.00321	CcSEcCtD
Levetiracetam—Mood swings—Capecitabine—colon cancer	0.000378	0.00318	CcSEcCtD
Levetiracetam—Ataxia—Capecitabine—colon cancer	0.000376	0.00316	CcSEcCtD
Levetiracetam—Alopecia—Vincristine—colon cancer	0.000375	0.00315	CcSEcCtD
Levetiracetam—Immune system disorder—Irinotecan—colon cancer	0.000373	0.00314	CcSEcCtD
Levetiracetam—Mediastinal disorder—Irinotecan—colon cancer	0.000372	0.00313	CcSEcCtD
Levetiracetam—Dehydration—Capecitabine—colon cancer	0.000371	0.00313	CcSEcCtD
Levetiracetam—Mental disorder—Vincristine—colon cancer	0.000371	0.00313	CcSEcCtD
Levetiracetam—Ecchymosis—Methotrexate—colon cancer	0.00037	0.00312	CcSEcCtD
Levetiracetam—Mouth ulceration—Methotrexate—colon cancer	0.00037	0.00312	CcSEcCtD
Levetiracetam—Liver function test abnormal—Capecitabine—colon cancer	0.000369	0.0031	CcSEcCtD
Levetiracetam—Alopecia—Irinotecan—colon cancer	0.000365	0.00307	CcSEcCtD
Levetiracetam—Abdominal pain upper—Capecitabine—colon cancer	0.000365	0.00307	CcSEcCtD
Levetiracetam—ABCB1—epithelium—colon cancer	0.000364	0.0187	CbGeAlD
Levetiracetam—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00036	0.00303	CcSEcCtD
Levetiracetam—Nasopharyngitis—Capecitabine—colon cancer	0.000357	0.00301	CcSEcCtD
Levetiracetam—Back pain—Vincristine—colon cancer	0.000357	0.003	CcSEcCtD
Levetiracetam—Muscular weakness—Capecitabine—colon cancer	0.000352	0.00296	CcSEcCtD
Levetiracetam—Alopecia—Fluorouracil—colon cancer	0.000349	0.00294	CcSEcCtD
Levetiracetam—Back pain—Irinotecan—colon cancer	0.000348	0.00293	CcSEcCtD
Levetiracetam—Asthma—Capecitabine—colon cancer	0.000345	0.00291	CcSEcCtD
Levetiracetam—Influenza—Capecitabine—colon cancer	0.000345	0.00291	CcSEcCtD
Levetiracetam—Agitation—Vincristine—colon cancer	0.000339	0.00285	CcSEcCtD
Levetiracetam—ABCB1—renal system—colon cancer	0.000338	0.0174	CbGeAlD
Levetiracetam—Bronchitis—Capecitabine—colon cancer	0.000332	0.00279	CcSEcCtD
Levetiracetam—Vertigo—Vincristine—colon cancer	0.000332	0.00279	CcSEcCtD
Levetiracetam—Hepatic failure—Methotrexate—colon cancer	0.000331	0.00278	CcSEcCtD
Levetiracetam—Leukopenia—Vincristine—colon cancer	0.00033	0.00278	CcSEcCtD
Levetiracetam—Pancytopenia—Capecitabine—colon cancer	0.000328	0.00276	CcSEcCtD
Levetiracetam—Vision blurred—Fluorouracil—colon cancer	0.000324	0.00273	CcSEcCtD
Levetiracetam—Vertigo—Irinotecan—colon cancer	0.000323	0.00272	CcSEcCtD
Levetiracetam—Neutropenia—Capecitabine—colon cancer	0.000323	0.00272	CcSEcCtD
Levetiracetam—Leukopenia—Irinotecan—colon cancer	0.000322	0.00271	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Capecitabine—colon cancer	0.000321	0.0027	CcSEcCtD
Levetiracetam—Convulsion—Vincristine—colon cancer	0.00032	0.00269	CcSEcCtD
Levetiracetam—Myalgia—Vincristine—colon cancer	0.000314	0.00264	CcSEcCtD
Levetiracetam—Weight increased—Capecitabine—colon cancer	0.000314	0.00264	CcSEcCtD
Levetiracetam—Cough—Irinotecan—colon cancer	0.000314	0.00264	CcSEcCtD
Levetiracetam—Weight decreased—Capecitabine—colon cancer	0.000312	0.00263	CcSEcCtD
Levetiracetam—Leukopenia—Fluorouracil—colon cancer	0.000308	0.00259	CcSEcCtD
Levetiracetam—Infestation NOS—Capecitabine—colon cancer	0.000308	0.00259	CcSEcCtD
Levetiracetam—Infestation—Capecitabine—colon cancer	0.000308	0.00259	CcSEcCtD
Levetiracetam—Depression—Capecitabine—colon cancer	0.000307	0.00258	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000305	0.00257	CcSEcCtD
Levetiracetam—Lethargy—Methotrexate—colon cancer	0.000303	0.00255	CcSEcCtD
Levetiracetam—Stomatitis—Capecitabine—colon cancer	0.0003	0.00253	CcSEcCtD
Levetiracetam—Infection—Vincristine—colon cancer	0.000299	0.00252	CcSEcCtD
Levetiracetam—Conjunctivitis—Capecitabine—colon cancer	0.000299	0.00252	CcSEcCtD
Levetiracetam—Urinary tract infection—Capecitabine—colon cancer	0.000299	0.00252	CcSEcCtD
Levetiracetam—Convulsion—Fluorouracil—colon cancer	0.000298	0.00251	CcSEcCtD
Levetiracetam—Confusional state—Irinotecan—colon cancer	0.000296	0.00249	CcSEcCtD
Levetiracetam—Nervous system disorder—Vincristine—colon cancer	0.000295	0.00249	CcSEcCtD
Levetiracetam—Thrombocytopenia—Vincristine—colon cancer	0.000295	0.00248	CcSEcCtD
Levetiracetam—Chest pain—Fluorouracil—colon cancer	0.000293	0.00247	CcSEcCtD
Levetiracetam—Myalgia—Fluorouracil—colon cancer	0.000293	0.00247	CcSEcCtD
Levetiracetam—Infection—Irinotecan—colon cancer	0.000291	0.00245	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Capecitabine—colon cancer	0.000291	0.00245	CcSEcCtD
Levetiracetam—Epistaxis—Capecitabine—colon cancer	0.00029	0.00244	CcSEcCtD
Levetiracetam—Nervous system disorder—Irinotecan—colon cancer	0.000288	0.00242	CcSEcCtD
Levetiracetam—Agranulocytosis—Capecitabine—colon cancer	0.000287	0.00242	CcSEcCtD
Levetiracetam—Thrombocytopenia—Irinotecan—colon cancer	0.000287	0.00242	CcSEcCtD
Levetiracetam—Anorexia—Vincristine—colon cancer	0.000287	0.00242	CcSEcCtD
Levetiracetam—Irritability—Methotrexate—colon cancer	0.000284	0.00239	CcSEcCtD
Levetiracetam—Confusional state—Fluorouracil—colon cancer	0.000283	0.00238	CcSEcCtD
Levetiracetam—Mood swings—Methotrexate—colon cancer	0.000282	0.00237	CcSEcCtD
Levetiracetam—ABCB1—lymphoid tissue—colon cancer	0.00028	0.0144	CbGeAlD
Levetiracetam—Anorexia—Irinotecan—colon cancer	0.00028	0.00235	CcSEcCtD
Levetiracetam—Ataxia—Methotrexate—colon cancer	0.00028	0.00235	CcSEcCtD
Levetiracetam—Infection—Fluorouracil—colon cancer	0.000279	0.00235	CcSEcCtD
Levetiracetam—Rhinitis—Capecitabine—colon cancer	0.000277	0.00233	CcSEcCtD
Levetiracetam—ABCB1—digestive system—colon cancer	0.000277	0.0142	CbGeAlD
Levetiracetam—Hepatitis—Capecitabine—colon cancer	0.000276	0.00233	CcSEcCtD
Levetiracetam—Nervous system disorder—Fluorouracil—colon cancer	0.000275	0.00232	CcSEcCtD
Levetiracetam—Thrombocytopenia—Fluorouracil—colon cancer	0.000275	0.00231	CcSEcCtD
Levetiracetam—Liver function test abnormal—Methotrexate—colon cancer	0.000274	0.00231	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Vincristine—colon cancer	0.000274	0.00231	CcSEcCtD
Levetiracetam—Pharyngitis—Capecitabine—colon cancer	0.000274	0.00231	CcSEcCtD
Levetiracetam—Insomnia—Vincristine—colon cancer	0.000272	0.00229	CcSEcCtD
Levetiracetam—Connective tissue disorder—Capecitabine—colon cancer	0.000271	0.00229	CcSEcCtD
Levetiracetam—Paraesthesia—Vincristine—colon cancer	0.00027	0.00228	CcSEcCtD
Levetiracetam—Anorexia—Fluorouracil—colon cancer	0.000268	0.00225	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000268	0.00225	CcSEcCtD
Levetiracetam—Insomnia—Irinotecan—colon cancer	0.000265	0.00223	CcSEcCtD
Levetiracetam—Paraesthesia—Irinotecan—colon cancer	0.000263	0.00222	CcSEcCtD
Levetiracetam—Decreased appetite—Vincristine—colon cancer	0.000262	0.0022	CcSEcCtD
Levetiracetam—Erythema multiforme—Capecitabine—colon cancer	0.000261	0.0022	CcSEcCtD
Levetiracetam—Somnolence—Irinotecan—colon cancer	0.000261	0.00219	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Vincristine—colon cancer	0.00026	0.00219	CcSEcCtD
Levetiracetam—Fatigue—Vincristine—colon cancer	0.00026	0.00219	CcSEcCtD
Levetiracetam—Eye disorder—Capecitabine—colon cancer	0.000258	0.00217	CcSEcCtD
Levetiracetam—Dyspepsia—Irinotecan—colon cancer	0.000258	0.00217	CcSEcCtD
Levetiracetam—Constipation—Vincristine—colon cancer	0.000258	0.00217	CcSEcCtD
Levetiracetam—Pain—Vincristine—colon cancer	0.000258	0.00217	CcSEcCtD
Levetiracetam—Asthma—Methotrexate—colon cancer	0.000257	0.00216	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000256	0.00215	CcSEcCtD
Levetiracetam—ABCB1—bone marrow—colon cancer	0.000255	0.0131	CbGeAlD
Levetiracetam—Decreased appetite—Irinotecan—colon cancer	0.000255	0.00215	CcSEcCtD
Levetiracetam—Eosinophilia—Methotrexate—colon cancer	0.000254	0.00214	CcSEcCtD
Levetiracetam—Insomnia—Fluorouracil—colon cancer	0.000254	0.00214	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Irinotecan—colon cancer	0.000253	0.00213	CcSEcCtD
Levetiracetam—Fatigue—Irinotecan—colon cancer	0.000253	0.00213	CcSEcCtD
Levetiracetam—Paraesthesia—Fluorouracil—colon cancer	0.000252	0.00212	CcSEcCtD
Levetiracetam—Pancreatitis—Methotrexate—colon cancer	0.000252	0.00212	CcSEcCtD
Levetiracetam—Constipation—Irinotecan—colon cancer	0.000251	0.00211	CcSEcCtD
Levetiracetam—Pain—Irinotecan—colon cancer	0.000251	0.00211	CcSEcCtD
Levetiracetam—Somnolence—Fluorouracil—colon cancer	0.00025	0.0021	CcSEcCtD
Levetiracetam—Immune system disorder—Capecitabine—colon cancer	0.00025	0.0021	CcSEcCtD
Levetiracetam—Mediastinal disorder—Capecitabine—colon cancer	0.000249	0.0021	CcSEcCtD
Levetiracetam—Dyspepsia—Fluorouracil—colon cancer	0.000247	0.00208	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Vincristine—colon cancer	0.000246	0.00207	CcSEcCtD
Levetiracetam—ABCB1—vagina—colon cancer	0.000245	0.0126	CbGeAlD
Levetiracetam—Decreased appetite—Fluorouracil—colon cancer	0.000244	0.00206	CcSEcCtD
Levetiracetam—Alopecia—Capecitabine—colon cancer	0.000244	0.00206	CcSEcCtD
Levetiracetam—Pancytopenia—Methotrexate—colon cancer	0.000244	0.00205	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000243	0.00204	CcSEcCtD
Levetiracetam—Mental disorder—Capecitabine—colon cancer	0.000242	0.00204	CcSEcCtD
Levetiracetam—Feeling abnormal—Irinotecan—colon cancer	0.000242	0.00203	CcSEcCtD
Levetiracetam—Malnutrition—Capecitabine—colon cancer	0.000241	0.00202	CcSEcCtD
Levetiracetam—Neutropenia—Methotrexate—colon cancer	0.00024	0.00202	CcSEcCtD
Levetiracetam—Pain—Fluorouracil—colon cancer	0.00024	0.00202	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Irinotecan—colon cancer	0.00024	0.00202	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Methotrexate—colon cancer	0.000239	0.00201	CcSEcCtD
Levetiracetam—Body temperature increased—Vincristine—colon cancer	0.000238	0.002	CcSEcCtD
Levetiracetam—Abdominal pain—Vincristine—colon cancer	0.000238	0.002	CcSEcCtD
Levetiracetam—Back pain—Capecitabine—colon cancer	0.000233	0.00196	CcSEcCtD
Levetiracetam—Body temperature increased—Irinotecan—colon cancer	0.000232	0.00195	CcSEcCtD
Levetiracetam—Abdominal pain—Irinotecan—colon cancer	0.000232	0.00195	CcSEcCtD
Levetiracetam—Feeling abnormal—Fluorouracil—colon cancer	0.000231	0.00195	CcSEcCtD
Levetiracetam—Drowsiness—Methotrexate—colon cancer	0.000229	0.00193	CcSEcCtD
Levetiracetam—Infestation—Methotrexate—colon cancer	0.000229	0.00193	CcSEcCtD
Levetiracetam—Infestation NOS—Methotrexate—colon cancer	0.000229	0.00193	CcSEcCtD
Levetiracetam—Depression—Methotrexate—colon cancer	0.000228	0.00192	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000227	0.00191	CcSEcCtD
Levetiracetam—Vision blurred—Capecitabine—colon cancer	0.000227	0.00191	CcSEcCtD
Levetiracetam—Tremor—Capecitabine—colon cancer	0.000225	0.0019	CcSEcCtD
Levetiracetam—Stomatitis—Methotrexate—colon cancer	0.000223	0.00188	CcSEcCtD
Levetiracetam—Conjunctivitis—Methotrexate—colon cancer	0.000223	0.00187	CcSEcCtD
Levetiracetam—Body temperature increased—Fluorouracil—colon cancer	0.000222	0.00187	CcSEcCtD
Levetiracetam—Hypersensitivity—Vincristine—colon cancer	0.000222	0.00187	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Methotrexate—colon cancer	0.000217	0.00182	CcSEcCtD
Levetiracetam—Epistaxis—Methotrexate—colon cancer	0.000216	0.00182	CcSEcCtD
Levetiracetam—Vertigo—Capecitabine—colon cancer	0.000216	0.00182	CcSEcCtD
Levetiracetam—Hypersensitivity—Irinotecan—colon cancer	0.000216	0.00182	CcSEcCtD
Levetiracetam—Asthenia—Vincristine—colon cancer	0.000216	0.00182	CcSEcCtD
Levetiracetam—Leukopenia—Capecitabine—colon cancer	0.000215	0.00181	CcSEcCtD
Levetiracetam—Agranulocytosis—Methotrexate—colon cancer	0.000214	0.0018	CcSEcCtD
Levetiracetam—Asthenia—Irinotecan—colon cancer	0.00021	0.00177	CcSEcCtD
Levetiracetam—Cough—Capecitabine—colon cancer	0.00021	0.00177	CcSEcCtD
Levetiracetam—Hypersensitivity—Fluorouracil—colon cancer	0.000207	0.00174	CcSEcCtD
Levetiracetam—ABCB1—liver—colon cancer	0.000206	0.0106	CbGeAlD
Levetiracetam—Diarrhoea—Vincristine—colon cancer	0.000206	0.00173	CcSEcCtD
Levetiracetam—Hepatitis—Methotrexate—colon cancer	0.000206	0.00173	CcSEcCtD
Levetiracetam—Chest pain—Capecitabine—colon cancer	0.000205	0.00172	CcSEcCtD
Levetiracetam—Arthralgia—Capecitabine—colon cancer	0.000205	0.00172	CcSEcCtD
Levetiracetam—Myalgia—Capecitabine—colon cancer	0.000205	0.00172	CcSEcCtD
Levetiracetam—Pharyngitis—Methotrexate—colon cancer	0.000204	0.00172	CcSEcCtD
Levetiracetam—Anxiety—Capecitabine—colon cancer	0.000204	0.00172	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000203	0.00171	CcSEcCtD
Levetiracetam—Diarrhoea—Irinotecan—colon cancer	0.000201	0.00169	CcSEcCtD
Levetiracetam—Dizziness—Vincristine—colon cancer	0.000199	0.00168	CcSEcCtD
Levetiracetam—Pruritus—Fluorouracil—colon cancer	0.000199	0.00167	CcSEcCtD
Levetiracetam—Confusional state—Capecitabine—colon cancer	0.000198	0.00167	CcSEcCtD
Levetiracetam—Infection—Capecitabine—colon cancer	0.000195	0.00164	CcSEcCtD
Levetiracetam—Erythema multiforme—Methotrexate—colon cancer	0.000194	0.00164	CcSEcCtD
Levetiracetam—Dizziness—Irinotecan—colon cancer	0.000194	0.00163	CcSEcCtD
Levetiracetam—Nervous system disorder—Capecitabine—colon cancer	0.000192	0.00162	CcSEcCtD
Levetiracetam—Eye disorder—Methotrexate—colon cancer	0.000192	0.00162	CcSEcCtD
Levetiracetam—Diarrhoea—Fluorouracil—colon cancer	0.000192	0.00162	CcSEcCtD
Levetiracetam—Thrombocytopenia—Capecitabine—colon cancer	0.000192	0.00162	CcSEcCtD
Levetiracetam—Vomiting—Vincristine—colon cancer	0.000191	0.00161	CcSEcCtD
Levetiracetam—Skin disorder—Capecitabine—colon cancer	0.000191	0.0016	CcSEcCtD
Levetiracetam—Rash—Vincristine—colon cancer	0.00019	0.0016	CcSEcCtD
Levetiracetam—Dermatitis—Vincristine—colon cancer	0.00019	0.0016	CcSEcCtD
Levetiracetam—Headache—Vincristine—colon cancer	0.000189	0.00159	CcSEcCtD
Levetiracetam—Anorexia—Capecitabine—colon cancer	0.000187	0.00157	CcSEcCtD
Levetiracetam—Vomiting—Irinotecan—colon cancer	0.000186	0.00157	CcSEcCtD
Levetiracetam—Immune system disorder—Methotrexate—colon cancer	0.000186	0.00156	CcSEcCtD
Levetiracetam—Dizziness—Fluorouracil—colon cancer	0.000186	0.00156	CcSEcCtD
Levetiracetam—Mediastinal disorder—Methotrexate—colon cancer	0.000185	0.00156	CcSEcCtD
Levetiracetam—Rash—Irinotecan—colon cancer	0.000185	0.00156	CcSEcCtD
Levetiracetam—Dermatitis—Irinotecan—colon cancer	0.000185	0.00156	CcSEcCtD
Levetiracetam—Headache—Irinotecan—colon cancer	0.000184	0.00155	CcSEcCtD
Levetiracetam—Alopecia—Methotrexate—colon cancer	0.000182	0.00153	CcSEcCtD
Levetiracetam—Mental disorder—Methotrexate—colon cancer	0.00018	0.00152	CcSEcCtD
Levetiracetam—Malnutrition—Methotrexate—colon cancer	0.000179	0.00151	CcSEcCtD
Levetiracetam—Nausea—Vincristine—colon cancer	0.000179	0.00151	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000179	0.00151	CcSEcCtD
Levetiracetam—Vomiting—Fluorouracil—colon cancer	0.000179	0.0015	CcSEcCtD
Levetiracetam—Insomnia—Capecitabine—colon cancer	0.000178	0.00149	CcSEcCtD
Levetiracetam—Rash—Fluorouracil—colon cancer	0.000177	0.00149	CcSEcCtD
Levetiracetam—Dermatitis—Fluorouracil—colon cancer	0.000177	0.00149	CcSEcCtD
Levetiracetam—Paraesthesia—Capecitabine—colon cancer	0.000176	0.00148	CcSEcCtD
Levetiracetam—Headache—Fluorouracil—colon cancer	0.000176	0.00148	CcSEcCtD
Levetiracetam—Nausea—Irinotecan—colon cancer	0.000174	0.00147	CcSEcCtD
Levetiracetam—Back pain—Methotrexate—colon cancer	0.000173	0.00146	CcSEcCtD
Levetiracetam—Dyspepsia—Capecitabine—colon cancer	0.000173	0.00145	CcSEcCtD
Levetiracetam—Decreased appetite—Capecitabine—colon cancer	0.000171	0.00144	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Capecitabine—colon cancer	0.000169	0.00143	CcSEcCtD
Levetiracetam—Fatigue—Capecitabine—colon cancer	0.000169	0.00142	CcSEcCtD
Levetiracetam—Vision blurred—Methotrexate—colon cancer	0.000169	0.00142	CcSEcCtD
Levetiracetam—Pain—Capecitabine—colon cancer	0.000168	0.00141	CcSEcCtD
Levetiracetam—Constipation—Capecitabine—colon cancer	0.000168	0.00141	CcSEcCtD
Levetiracetam—Nausea—Fluorouracil—colon cancer	0.000167	0.0014	CcSEcCtD
Levetiracetam—Feeling abnormal—Capecitabine—colon cancer	0.000162	0.00136	CcSEcCtD
Levetiracetam—Vertigo—Methotrexate—colon cancer	0.000161	0.00135	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Capecitabine—colon cancer	0.000161	0.00135	CcSEcCtD
Levetiracetam—Leukopenia—Methotrexate—colon cancer	0.00016	0.00135	CcSEcCtD
Levetiracetam—ABCB1—lymph node—colon cancer	0.000158	0.00813	CbGeAlD
Levetiracetam—Cough—Methotrexate—colon cancer	0.000156	0.00132	CcSEcCtD
Levetiracetam—Body temperature increased—Capecitabine—colon cancer	0.000155	0.00131	CcSEcCtD
Levetiracetam—Abdominal pain—Capecitabine—colon cancer	0.000155	0.00131	CcSEcCtD
Levetiracetam—Convulsion—Methotrexate—colon cancer	0.000155	0.00131	CcSEcCtD
Levetiracetam—Arthralgia—Methotrexate—colon cancer	0.000152	0.00128	CcSEcCtD
Levetiracetam—Chest pain—Methotrexate—colon cancer	0.000152	0.00128	CcSEcCtD
Levetiracetam—Myalgia—Methotrexate—colon cancer	0.000152	0.00128	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000151	0.00127	CcSEcCtD
Levetiracetam—Confusional state—Methotrexate—colon cancer	0.000147	0.00124	CcSEcCtD
Levetiracetam—Infection—Methotrexate—colon cancer	0.000145	0.00122	CcSEcCtD
Levetiracetam—Hypersensitivity—Capecitabine—colon cancer	0.000145	0.00122	CcSEcCtD
Levetiracetam—Nervous system disorder—Methotrexate—colon cancer	0.000143	0.00121	CcSEcCtD
Levetiracetam—Thrombocytopenia—Methotrexate—colon cancer	0.000143	0.0012	CcSEcCtD
Levetiracetam—Skin disorder—Methotrexate—colon cancer	0.000142	0.00119	CcSEcCtD
Levetiracetam—Asthenia—Capecitabine—colon cancer	0.000141	0.00119	CcSEcCtD
Levetiracetam—Anorexia—Methotrexate—colon cancer	0.000139	0.00117	CcSEcCtD
Levetiracetam—Pruritus—Capecitabine—colon cancer	0.000139	0.00117	CcSEcCtD
Levetiracetam—Diarrhoea—Capecitabine—colon cancer	0.000134	0.00113	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000133	0.00112	CcSEcCtD
Levetiracetam—Insomnia—Methotrexate—colon cancer	0.000132	0.00111	CcSEcCtD
Levetiracetam—Paraesthesia—Methotrexate—colon cancer	0.000131	0.0011	CcSEcCtD
Levetiracetam—Somnolence—Methotrexate—colon cancer	0.00013	0.00109	CcSEcCtD
Levetiracetam—Dizziness—Capecitabine—colon cancer	0.00013	0.00109	CcSEcCtD
Levetiracetam—Dyspepsia—Methotrexate—colon cancer	0.000129	0.00108	CcSEcCtD
Levetiracetam—Decreased appetite—Methotrexate—colon cancer	0.000127	0.00107	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Methotrexate—colon cancer	0.000126	0.00106	CcSEcCtD
Levetiracetam—Fatigue—Methotrexate—colon cancer	0.000126	0.00106	CcSEcCtD
Levetiracetam—Pain—Methotrexate—colon cancer	0.000125	0.00105	CcSEcCtD
Levetiracetam—Vomiting—Capecitabine—colon cancer	0.000125	0.00105	CcSEcCtD
Levetiracetam—Rash—Capecitabine—colon cancer	0.000124	0.00104	CcSEcCtD
Levetiracetam—Dermatitis—Capecitabine—colon cancer	0.000124	0.00104	CcSEcCtD
Levetiracetam—Headache—Capecitabine—colon cancer	0.000123	0.00104	CcSEcCtD
Levetiracetam—Feeling abnormal—Methotrexate—colon cancer	0.00012	0.00101	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Methotrexate—colon cancer	0.000119	0.00101	CcSEcCtD
Levetiracetam—Nausea—Capecitabine—colon cancer	0.000117	0.000981	CcSEcCtD
Levetiracetam—Body temperature increased—Methotrexate—colon cancer	0.000116	0.000972	CcSEcCtD
Levetiracetam—Abdominal pain—Methotrexate—colon cancer	0.000116	0.000972	CcSEcCtD
Levetiracetam—Hypersensitivity—Methotrexate—colon cancer	0.000108	0.000906	CcSEcCtD
Levetiracetam—Asthenia—Methotrexate—colon cancer	0.000105	0.000882	CcSEcCtD
Levetiracetam—Pruritus—Methotrexate—colon cancer	0.000103	0.00087	CcSEcCtD
Levetiracetam—Diarrhoea—Methotrexate—colon cancer	0.0001	0.000842	CcSEcCtD
Levetiracetam—Dizziness—Methotrexate—colon cancer	9.66e-05	0.000813	CcSEcCtD
Levetiracetam—Vomiting—Methotrexate—colon cancer	9.29e-05	0.000782	CcSEcCtD
Levetiracetam—Rash—Methotrexate—colon cancer	9.21e-05	0.000776	CcSEcCtD
Levetiracetam—Dermatitis—Methotrexate—colon cancer	9.2e-05	0.000775	CcSEcCtD
Levetiracetam—Headache—Methotrexate—colon cancer	9.15e-05	0.000771	CcSEcCtD
Levetiracetam—Nausea—Methotrexate—colon cancer	8.68e-05	0.000731	CcSEcCtD
